Understanding Your Hepatitis B Blood Tests
Understanding Your Hepatitis B Blood Tests
Understanding Your Hepatitis B Blood Tests
Understanding your hepatitis B blood test results can be confusing. It is important to talk to your doctor so you understand
your test results and your hepatitis B status. This fact sheet can help you understand and answer questions about what
your blood tests mean and if you are infected, protected or at risk for hepatitis B. Be sure to ask for a printed copy of any
blood tests so you can understand your results.
Only one sample of blood is needed for a hepatitis B blood test, but the "Hepatitis B Panel" includes three parts. All three
test results are needed to fully understand someone's hepatitis B status.
2. Hepatitis B Surface Antibody (HbsAb or Anti-HBs) – The "surface antibody" is formed in response to the
hepatitis B virus. Your body can make this antibody if you have been vaccinated, or if you have recovered
from a hepatitis B infection. If this test is positive or "reactive," then your immune system has successfully
developed a protective antibody against the hepatitis B virus. This will provide long-term protection against
future hepatitis B infection. Someone who is HBsAb+ is not infected and cannot pass the virus to others.
3. Hepatitis B Core Antibody (HBcAb or Anti-HBc) – This antibody does not provide any protection or immunity
against the hepatitis B virus. A positive or "reactive" test indicates that a person may have been infected with
the hepatitis B virus at some point in time. This test is often used by blood banks to screen blood donation,
however, all three test results are needed to make a diagnosis.
+ - +
Positive surface antigen (HBsAg), which means
hepatitis B virus is present. Can spread the virus to
others. Find a doctor who knows about hepatitis B
for more tests and care.
- - +
Could be Infected - Need More Testing
Different interpretations are possible. Person might be
infected, susceptible, or have a resolved infection.
Hepatitis B e-Antigen (HBeAg) – This is a viral protein made by the hepatitis B virus that is released from infected liver
cells into the blood. This test detects how much virus is in the blood as a result of very active viral replication. A negative
test result indicates the virus may not be actively reproducing in the liver. In general, a person is considered very
infectious when the test is positive, and less infectious when the test is negative. The loss of e-Antigen can occur
naturally or as a result of drug treatment. Sometimes a negative test result can indicate a mutant hepatitis B virus is
present. So, the absence of e-Antigen does not always mean there is little or no active viral replication. The doctor can
confirm with additional tests.
Hepatitis B e-Antibody (HBeAb or Anti-HBe) – This is not a protective antibody and is made in response to the
hepatitis B e-Antigen. Once the virus stops actively replicating in the liver, the e-antigen protein can disappear and then
the e-Antibody appears (making this a positive test result or HBeAb+). This can happen spontaneously or after treatment
– and while the clinical significance of this result is not fully understood, it is generally considered good.
Hepatitis B Virus DNA – This test measures the amount of hepatitis B DNA in the blood, which tells how actively the
virus is replicating. It is a more expensive test that may not be available in some countries. It should be considered in
conjunction with other information such as e-Antigen status, liver enzymes and possibly imaging studies. The viral load is
usually measured in “international units per milliliter” (IU/mL), but may also be measured in “copies per milliliter” (cp/ml).
There are typically 5 copies in 1 international unit.
HBsAg Quantification (Quantitative Hepatitis B Surface Antigen/qHBsAg) – This blood test measures the amount of
hepatitis B surface antigen in the blood. When used in combination with the HBV DNA test, qHBsAg can provide a liver
specialist with additional insights to an individual’s HBV infection. It can also be used in predicting and monitoring
treatment response.
Other Tests:
Liver Function Tests and Liver Enzymes – These blood tests measure potential liver damage (or liver inflammation)
caused by the hepatitis B virus. When the liver is injured, the liver enzymes can leak into the bloodstream. The larger the
number, the greater the potential liver damage.
Alanine Aminotransferase (ALT or SGPT) – This enzyme is monitored closely with a hepatitis B infection and is found
almost exclusively in the liver. This test is useful in deciding whether a person would benefit from treatment or for
evaluating how well a person is responding to therapy. The upper limits of normal ALT for men is 30 units/liter and for
women is 19 units/liter. ALT may be elevated for reasons other than hepatitis B infection.
Alpha-Feto Protein (AFP) – This blood test is used to screen for the development of primary liver cancer in those living
with chronic hepatitis B and should be tested at every visit. Non-pregnant adults should not have elevated AFP. If an
individual does have elevated AFP, then more tests and imaging studies should be ordered.
Imaging Studies of the Liver – Your doctor may order an ultrasound, FibroTest, or transient elastography to evaluate or
monitor liver damage (e.g. inflammation, fibrosis, cirrhosis) and to screen for primary liver cancer.